VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”) and Yarrow Bioscience, Inc. (“Yarrow”) announce that they have entered into a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction (the “Merger”). Upon completion of the Merger, the combined company expects to operate as Yarrow Bioscience, Inc. and trade on Nasdaq under the ticker symbol “YARW”. In support of the Merger, a syndicate of industry-leading healthcare investors has committed to pre-closing financings in Yarrow totaling approximately $200.0 million in cash proceeds.
Read the full article: VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement //
Source: https://www.globenewswire.com/news-release/2025/12/17/3206928/0/en/VYNE-Therapeutics-and-Yarrow-Bioscience-Announce-Merger-Agreement.html